Meng Hongwei, Wang Yulan, Li Zhifu, Yan Jun, Yu Wenjun, Chen Changqiang
Department of Clinical Laboratory Medicine Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine Shanghai People's Republic of China.
Health Sci Rep. 2024 Nov 29;7(12):e70214. doi: 10.1002/hsr2.70214. eCollection 2024 Dec.
Pathogenic microbial infections are closely related to the development and prognosis of esophageal cancer. The distribution and resistance of pathogens in different diseases are regional and gradually change over time. This study aimed to determine the distribution and drug resistance of pathogens isolated from patients with esophageal cancer and provide a reference for the rational use of antibiotics.
The results of strain identification and antimicrobial susceptibility testing of pathogens in patients with esophageal cancer from January 2013 to December 2022 at our hospital were retrospectively analyzed. SPSS Statistics 26.0 (IBM) and R software 4.3.1 were used for data analysis.
In total, 2322 non-repetitive pathogens were isolated from 14,037 samples. Of all strains, 1713 (73.77%) were Gram-negative bacteria, 483 (20.80%) were Gram-positive bacteria, and 126 (5.43%) were fungi. The top 10 pathogens were (19.81%), (12.88%), (9.91%), (9.82%), (7.54%), (3.92%), (3.19%), (3.14%), (2.97%), and (2.15%). The isolation rate of showed an upward trend (< 0.05). The resistance rates of , , , and Enterobacteriaceae bacteria to some common antibiotics showed a tendency to change (< 0.05), and 2019 became a turning point to some extent. All common Gram-positive pathogens were sensitive to vancomycin, except for three spp. isolates that showed intrinsic resistance. The prevalence of MRSA was 65.14% (114/175) in this study. In addition, the resistance rates of MRSA and MSSA to moxifloxacin, ciprofloxacin, levofloxacin, erythromycin, clindamycin, and penicillin were significantly different (< 0.001).
Pathogens are diverse in patients with esophageal cancer, with the most common being , followed by . The pathogens exhibited different patterns of resistance. Antibiotics should be used rationally according to pathogen resistance patterns.
病原微生物感染与食管癌的发生发展及预后密切相关。不同疾病中病原体的分布及耐药情况存在地区差异且随时间逐渐变化。本研究旨在确定食管癌患者分离出的病原体的分布及耐药情况,为合理使用抗生素提供参考。
回顾性分析2013年1月至2022年12月我院食管癌患者病原体的菌株鉴定及药敏试验结果。采用SPSS Statistics 26.0(IBM公司)和R软件4.3.1进行数据分析。
共从14037份样本中分离出2322株非重复病原体。在所有菌株中,革兰阴性菌1713株(73.77%),革兰阳性菌483株(20.80%),真菌126株(5.43%)。前10位病原体分别为(19.81%)、(12.88%)、(9.91%)、(9.82%)、(7.54%)、(3.92%)、(3.19%)、(3.14%)、(2.97%)和(2.15%)。的分离率呈上升趋势(<0.05)。、、和肠杆菌科细菌对某些常用抗生素的耐药率呈现变化趋势(<0.05),2019年在一定程度上成为一个转折点。除3株表现出固有耐药性的分离株外,所有常见革兰阳性病原体对万古霉素敏感。本研究中耐甲氧西林金黄色葡萄球菌(MRSA)的患病率为65.14%(114/175)。此外,MRSA和甲氧西林敏感金黄色葡萄球菌(MSSA)对莫西沙星、环丙沙星、左氧氟沙星、红霉素、克林霉素和青霉素的耐药率差异有统计学意义(<0.001)。
食管癌患者的病原体种类多样,最常见的是,其次是。病原体表现出不同的耐药模式。应根据病原体耐药模式合理使用抗生素。